Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database

KAORI ITO; TAKENAO KOSEKI; MISAKI MORISAKU; SHIGEKI YAMADA; NOBUKI HAYAKAWA

doi:10.21873/invivo.13520

Article Information

vol. 38 no. 2 923-927

DOI

https://doi.org/10.21873/invivo.13520

PMID

38418128

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received November 22, 2023
Revision received December 27, 2023
Accepted December 28, 2023
Published online February 28, 2024.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

KAORI ITO¹,²,³ ⇑,
TAKENAO KOSEKI²,
MISAKI MORISAKU²,
SHIGEKI YAMADA² and
NOBUKI HAYAKAWA¹

¹Faculty of Pharmacy, Meijo University, Nagoya, Japan;
²Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan;
³Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan

Correspondence to: Kaori Ito, Ph.D., Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan. Tel: +81 528321151, e-mail: itoka{at}meijo-u.ac.jp

View Full Text